Scholar Rock's Weight-Loss Drug Preserves Muscle in Phase 2 Trial
Scholar Rock's investigational drug apitegromab, when combined with Eli Lilly’s Zepbound, helped preserve lean muscle mass in patients undergoing weight loss, addressing concerns about muscle loss with obesity treatments.